Your browser is no longer supported. Please, upgrade your browser.
Settings
TRXC TransEnterix, Inc. daily Stock Chart
TRXC [AMEX]
TransEnterix, Inc.
Index- P/E- EPS (ttm)-8.03 Insider Own0.80% Shs Outstand28.91M Perf Week-2.25%
Market Cap21.58M Forward P/E- EPS next Y-1.79 Insider Trans51.24% Shs Float47.76M Perf Month-0.41%
Income-148.70M PEG- EPS next Q-0.38 Inst Own18.90% Short Float5.06% Perf Quarter-65.58%
Sales7.00M P/S3.08 EPS this Y-124.30% Inst Trans78.41% Short Ratio1.26 Perf Half Y-84.35%
Book/sh2.32 P/B0.18 EPS next Y-7.20% ROA-129.30% Target Price- Perf Year-97.63%
Cash/sh- P/C- EPS next 5Y- ROE-187.10% 52W Range0.28 - 25.22 Perf YTD-71.90%
Dividend- P/FCF- EPS past 5Y-0.80% ROI-272.90% 52W High-98.36% Beta2.75
Dividend %- Quick Ratio2.30 Sales past 5Y84.30% Gross Margin- 52W Low47.50% ATR0.03
Employees160 Current Ratio3.10 Sales Q/Q-72.70% Oper. Margin- RSI (14)51.17 Volatility7.12% 7.91%
OptionableYes Debt/Eq0.00 EPS Q/Q56.40% Profit Margin- Rel Volume0.48 Prev Close0.42
ShortableYes LT Debt/Eq0.00 EarningsMay 14 BMO Payout- Avg Volume1.92M Price0.41
Recom1.70 SMA20-1.11% SMA503.49% SMA200-87.29% Volume928,374 Change-2.43%
Aug-08-19Downgrade RBC Capital Mkts Outperform → Sector Perform $3 → $1
May-22-19Initiated Piper Jaffray Neutral $1.60
May-14-19Upgrade BTIG Research Neutral → Buy $3
Nov-09-18Upgrade Ladenburg Thalmann Neutral → Buy
May-29-18Downgrade Ladenburg Thalmann Buy → Neutral
Oct-30-17Reiterated Stifel Buy $3.75 → $4
Jan-19-17Downgrade Raymond James Outperform → Mkt Perform
May-11-16Downgrade Lake Street Buy → Hold $2
Apr-21-16Reiterated Lake Street Buy $7 → $2
May-27-14Initiated RBC Capital Mkts Outperform $6
May-21-20 06:55AM  
May-17-20 03:01PM  
May-14-20 06:55AM  
May-13-20 12:00PM  
May-05-20 06:55AM  
Apr-09-20 10:21AM  
Apr-08-20 12:00PM  
10:38AM  
Mar-25-20 02:45PM  
Mar-16-20 04:05PM  
02:30PM  
10:18AM  
08:16AM  
Mar-13-20 06:55AM  
Mar-09-20 06:55AM  
Mar-06-20 08:15AM  
Mar-05-20 04:15PM  
Mar-02-20 06:45AM  
Feb-28-20 06:55AM  
Feb-12-20 06:50AM  
Feb-10-20 04:15PM  
Feb-05-20 09:23AM  
Jan-29-20 04:05PM  
Jan-21-20 06:55AM  
Jan-17-20 09:34AM  
Jan-14-20 06:55AM  
Jan-08-20 06:55AM  
Jan-06-20 06:55AM  
Jan-03-20 07:55AM  
06:55AM  
Jan-02-20 04:05PM  
Dec-24-19 09:37AM  
Dec-14-19 05:18PM  
Dec-11-19 11:30AM  
Dec-04-19 08:49AM  
08:36AM  
Nov-26-19 06:55AM  
06:55AM  
Nov-14-19 01:41PM  
08:53AM  
Nov-12-19 05:35PM  
04:05PM  
Nov-08-19 04:25PM  
04:20PM  
Nov-05-19 10:32AM  
Oct-31-19 04:15PM  
Oct-30-19 06:18AM  
Oct-24-19 09:00AM  
Oct-17-19 04:30PM  
Oct-03-19 08:49AM  
Sep-18-19 10:23AM  
Sep-13-19 08:39AM  
Sep-12-19 01:08PM  
Sep-11-19 04:05PM  
Sep-04-19 04:05PM  
Aug-28-19 02:28PM  
Aug-26-19 08:37AM  
Aug-21-19 06:55AM  
Aug-09-19 03:15PM  
Aug-08-19 05:13PM  
Aug-07-19 07:35PM  
04:05PM  
Aug-05-19 08:42AM  
Jul-31-19 10:36AM  
Jul-25-19 04:05PM  
Jul-11-19 11:30AM  
Jul-10-19 04:14PM  
01:58PM  
12:48PM  
Jul-08-19 11:18AM  
Jun-27-19 04:16PM  
Jun-12-19 11:00PM  
Jun-06-19 06:55AM  
May-28-19 12:12PM  
06:55AM  
May-22-19 01:33AM  
May-18-19 08:03AM  
May-17-19 08:50AM  
May-14-19 04:03PM  
May-10-19 09:12AM  
12:24AM  
May-09-19 08:10PM  
06:35PM  
05:27PM  
04:05PM  
May-07-19 06:55AM  
May-02-19 10:32AM  
Apr-24-19 06:55AM  
Apr-19-19 03:47PM  
Mar-28-19 06:55AM  
Mar-19-19 08:42AM  
Mar-14-19 07:07AM  
Mar-06-19 02:50PM  
Feb-26-19 06:27PM  
10:34AM  
06:55AM  
Feb-20-19 09:45AM  
Feb-12-19 06:55AM  
Jan-17-19 10:00AM  
Jan-15-19 06:55AM  
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company's products include Senhance System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Biffi AndreaDirectorFeb 24Buy1.24151,219187,512199,738Feb 25 06:15 PM
Fernando Anthony C. J.President and CEOFeb 04Option Exercise0.0033,795054,449Feb 06 08:04 PM
Smith Eric AChief Commercial OfficerFeb 04Option Exercise0.0012,821012,821Feb 06 08:03 PM
Starling William N JRDirectorDec 19Sale1.429,60213,64811,968Dec 20 07:44 PM